Back to Search
Start Over
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1995 Nov; Vol. 39 (11), pp. 2478-83. - Publication Year :
- 1995
-
Abstract
- Among Escherichia coli organisms isolated at St. Thomas's Hospital during the years 1990 to 1994, the frequency of resistance to amoxicillin-clavulanic acid (tested by disk diffusion in a ratio of 2:1) remained constant at about 5% of patient isolates (10 to 15% of the 41 to 45% that were amoxicillin resistant). Mechanisms of increased resistance were determined for 72 consecutively collected such amoxicillin-clavulanic acid-resistant isolates. MICs of the combination were 16-8 micrograms/ml for 51 (71%) of these and > or = 32-16 micrograms/ml for the remainder. The predominant mechanism was hyperproduction of enzymes isoelectrically cofocusing with TEM-1 (beta-lactamase activities, > 200 nmol of nitrocefin hydrolyzed per min per mg of protein) which was found in 44 isolates (61%); two isolates produced smaller amounts (approximately 150 nmol/min/mg) of such enzymes, and two isolates hyperproduced enzymes cofocusing with TEM-2. Eleven isolates produced enzymes cofocusing with OXA-1 beta-lactamase, which has previously been associated with resistance to amoxicillin-clavulanic acid. Ten isolates produced increased amounts of chromosomal beta-lactamase, and four of these additionally produced TEM-1 or TEM-2. Three isolates produced inhibitor-resistant TEM-group enzymes. In one of the enzymes (pI, 5.4), the amino acid sequence change was Met-67-->Val, and thus the enzyme is identical to TEM-34. Another (pI, 5.4) had the substitution Met-67-->Ile and is identical to IRT-I67, which we propose now be given the designation TEM-40. The third (pI, 5.2) had the substitution Arg-241-->Thr; this enzyme has not been reported previously and should be called TEM-41. The rarity and diversity of inhibitor-resistant TEM-group enzymes suggest that they are the result of spontaneous mutations that have not yet spread.
- Subjects :
- Amoxicillin pharmacology
Amoxicillin-Potassium Clavulanate Combination
Base Sequence
Clavulanic Acids pharmacology
DNA, Bacterial chemistry
DNA, Bacterial isolation & purification
Drug Resistance, Microbial
Escherichia coli enzymology
Escherichia coli genetics
Isoelectric Focusing
Microbial Sensitivity Tests
Molecular Sequence Data
Penicillins pharmacology
Polymerase Chain Reaction
beta-Lactamases metabolism
Ampicillin Resistance
Drug Therapy, Combination pharmacology
Escherichia coli drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0066-4804
- Volume :
- 39
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 8585729
- Full Text :
- https://doi.org/10.1128/AAC.39.11.2478